These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1911017)

  • 1. Effect of single doses of cisapride and ranitidine administered simultaneously on plasma concentrations of cisapride and ranitidine.
    Rowbotham DJ; Milligan K; McHugh P
    Br J Anaesth; 1991 Sep; 67(3):302-5. PubMed ID: 1911017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
    Lee HT; Lee YJ; Chung SJ; Shim CK
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of rectal cisapride on morphine-induced gastric stasis.
    Kluger MT; Plummer JL; Owen H
    Anaesth Intensive Care; 1991 Aug; 19(3):346-50. PubMed ID: 1767901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No effect of cisapride on paracetamol absorption after oral simultaneous administration.
    Rowbotham DJ; Parnacott S; Nimmo WS
    Eur J Clin Pharmacol; 1992; 42(2):235-6. PubMed ID: 1618258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the placental transfer of cisapride in sheep. Plasma levels in the pregnant ewe, the fetus, and the lamb.
    Veereman-Wauters G; Monbaliu J; Meuldermans W; Woestenborghs R; Verlinden M; Heykants J; Rudolph CD
    Drug Metab Dispos; 1991; 19(1):168-72. PubMed ID: 1673393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.
    Tack J; Coremans G; Janssens J
    Drug Saf; 1995 Jun; 12(6):384-92. PubMed ID: 8527013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
    Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D
    Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisapride: a new class of prokinetic agent. The ACG Committee on FDA-related matters. American College of Gastroenterology.
    McCallum RW
    Am J Gastroenterol; 1991 Feb; 86(2):135-49. PubMed ID: 1992624
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
    Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
    Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cisapride: pharmacology, current therapeutic results and future prospects].
    Fraitag B; Cloarec D; Galmiche JP
    Gastroenterol Clin Biol; 1989 Mar; 13(3):265-76. PubMed ID: 2659417
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
    McKenna CJ; Mills JG; Goodwin C; Wood JR
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cisapride on morphine absorption after oral administration of sustained-release morphine.
    Rowbotham DJ; Milligan K; McHugh P
    Br J Anaesth; 1991 Oct; 67(4):421-5. PubMed ID: 1718364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The place of cisapride in therapeutics: an interim verdict.
    Hawkey CJ
    Aliment Pharmacol Ther; 1991 Aug; 5(4):351-6. PubMed ID: 1777545
    [No Abstract]   [Full Text] [Related]  

  • 15. Cisapride: its use in children.
    Newell SJ
    Br J Hosp Med; 1990 Dec; 44(6):408-9. PubMed ID: 2081312
    [No Abstract]   [Full Text] [Related]  

  • 16. Report from the NASPGN Therapeutics Subcommittee. Cisapride and the attack of the P-450s.
    Shulman RJ
    J Pediatr Gastroenterol Nutr; 1996 Nov; 23(4):395-7. PubMed ID: 8956172
    [No Abstract]   [Full Text] [Related]  

  • 17. Action of cisapride on rat colonic secretion.
    Bandi JC; Rosembeck G; De Paula JA; Ledesma de Paolo MI; Celener D; Gravelle PC; Bustos Fernandez L
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):319-24. PubMed ID: 8232608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
    N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and suggested oral dosing regimen of cisapride: a study in healthy cats.
    LeGrange SN; Boothe DM; Herndon S; Willard MD
    J Am Anim Hosp Assoc; 1997; 33(6):517-23. PubMed ID: 9358420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastroprokinetics in the treatment of stomach ulcer: a direct comparative study of cisapride versus ranitidine].
    Simon B; Nonnenmacher A; Dammann HG; Müller P
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():85-8. PubMed ID: 2192510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.